Investing In
United Kingdom
20 August 2025
'Very knowledgeable, supportive and responsive', Fieldfisher‘s life sciences team is well placed to advise on funding and transactions for pharma product development and programmes, as well as regulatory matters concerning new technologies and development. The team is led by ’industry veteran’ Janita Good, a transactional lawyer experienced in corporate and IP partnering deals, with specific expertise in complex structuring and M&A exits. Sarah Ellson draws on her public law experience to advise on regulatory and compliance matters, supporting market entrants navigating the regulatory landscape. Sarah Tedstone is an expert in health data privacy and compliance. John Linneker is no longer at the firm.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Very knowledgeable, supportive and responsive. They give clear advice.’
'Janita Good is a longstanding industry veteran with extensive experience advising on both corporate and IP transfer matters. She understands her clients' businesses and is a trusted adviser to them. Overall, the firm has a very strong focus on life sciences and leverages its IP expertise to also advise on transactional matters.'
'Very knowledgeable and supportive. Highly responsive.'
'Really strong and personable team.'
'A great breadth of expertise, and I haven't found a situation where they couldn't advise. As an AIM-listed company, we have to rely on the quality of their work, as so much of what we require is subject to the regulatory environment and the rules that apply. A key differentiator with Fieldfisher is the time they have taken to get to know and understand our business and as a consequence, I do believe they keep us in mind for future opportunities, given the reach of their network, examples of which would be links to advise in other jurisdictions beyond UK/EU, such as the GCC, and potential sources of funding.'
Key clients
- Novartis
- CRISM Therapeutics Corporation and CRISM Therapeutics Limited
- Myeloma
- Synairgen PLC
- Randox Laboratories
- Convatec
- ValiRX
- Jersey Hemp
- UK BioBank
- Biogen
- Numan
Work highlights
Advised Novartis Pharma AG on a global project involving managing external Counsel identifying the local regulations and legislation in relation to Patient Support Programmes (PSPs) in over 38 countries.
Advised CRISM Therapeutics Corporation on its reverse takeover, acquisition of Extruded Pharmaceuticals Limited ("EPL") and re-admission to trading on AIM.
Representing Myeloma UK in a further appeal against a decision made by the National Institute for Health and Care Excellence (NICE).
Practice head
Janita Good
Other key lawyers
Sarah Ellson; Sarah Tedstone; Sonal Patel Oliva; Vicky Reinhardt